TD Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
TD Asset Management's IRMD Position: Q2 2026 in Review
TD Asset Management held its iRadimed (IRMD) position steady in Q2 2026 at 3,998 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.
TD Asset Management first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $389K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- TD Asset Management held 3,998 shares of iRadimed worth $382K as of Q2 2026.
- TD Asset Management left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1190 holding.
- TD Asset Management first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
- TD Asset Management's iRadimed position peaked at $389K in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.